Biomarkers to Detect Early-Stage Colorectal Cancer
- PMID: 35203465
- PMCID: PMC8869393
- DOI: 10.3390/biomedicines10020255
Biomarkers to Detect Early-Stage Colorectal Cancer
Abstract
Colorectal cancer is a leading cause of mortality worldwide. The high incidence and the acceleration of incidence in younger people reinforces the need for better techniques of early detection. The use of noninvasive biomarkers has potential to more accurately inform how patients are prioritised for clinical investigation, which, in turn, may ultimately translate into improved survival for those subsequently found to have curable-stage CRC. This review surveys a wide range of CRC biomarkers that may (alone or in combination) identify symptomatic patients presenting in primary care who should be progressed for clinical investigation.
Keywords: biomarker; colorectal cancer; diagnosis; early stage; noninvasive testing.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Biomarkers in Colorectal Cancer Screening.J Natl Compr Canc Netw. 2016 Aug;14(8):1033-40. doi: 10.6004/jnccn.2016.0109. J Natl Compr Canc Netw. 2016. PMID: 27496118 Review.
-
Roles of Methylated DNA Biomarkers in Patients with Colorectal Cancer.Dis Markers. 2019 Mar 3;2019:2673543. doi: 10.1155/2019/2673543. eCollection 2019. Dis Markers. 2019. PMID: 30944663 Free PMC article. Review.
-
Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1. Ont Health Technol Assess Ser. 2009. PMID: 23074514 Free PMC article.
-
Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.Clin Gastroenterol Hepatol. 2018 Apr;16(4):504-512.e11. doi: 10.1016/j.cgh.2017.07.011. Epub 2017 Jul 18. Clin Gastroenterol Hepatol. 2018. PMID: 28733262 Free PMC article.
-
Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal Cancer.Int J Mol Sci. 2019 Dec 2;20(23):6082. doi: 10.3390/ijms20236082. Int J Mol Sci. 2019. PMID: 31810358 Free PMC article.
Cited by
-
EMR1/ADGRE1 Expression in Cancer Cells Upregulated by Tumor-Associated Macrophages Is Related to Poor Prognosis in Colorectal Cancer.Biomedicines. 2022 Dec 2;10(12):3121. doi: 10.3390/biomedicines10123121. Biomedicines. 2022. PMID: 36551877 Free PMC article.
-
Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA-Approved Drugs.Int J Mol Sci. 2023 Sep 3;24(17):13618. doi: 10.3390/ijms241713618. Int J Mol Sci. 2023. PMID: 37686423 Free PMC article. Review.
-
The Importance of Evaluating Serum Levels of Tumor Markers M2-PK and Inhibin A in Patients Undergoing Colonoscopy.Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231194492. doi: 10.1177/15330338231194492. Technol Cancer Res Treat. 2023. PMID: 37574835 Free PMC article.
-
A Hybrid Algorithm of ML and XAI to Prevent Breast Cancer: A Strategy to Support Decision Making.Cancers (Basel). 2023 Apr 25;15(9):2443. doi: 10.3390/cancers15092443. Cancers (Basel). 2023. PMID: 37173910 Free PMC article.
-
Early Onset Colorectal Cancer: Molecular Underpinnings Accelerating Occurrence.Cell Mol Gastroenterol Hepatol. 2025;19(2):101425. doi: 10.1016/j.jcmgh.2024.101425. Epub 2024 Nov 5. Cell Mol Gastroenterol Hepatol. 2025. PMID: 39510499 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources